{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:55:42Z","timestamp":1774353342418,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>COronaVIrus Disease 19 (COVID-19) was first reported in Wuhan, China in December 2019 and is now pandemic all over the world. The purpose of this review is to highlight the possible ocular presentation of COVID-19 infection and the consequence of the pandemic in the daily ophthalmology routine. A total of 9 articles was included by searching PubMed database for articles published between December 2019 and April 2020.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Main body<\/jats:title>\n<jats:p>Conjunctivitis (and keratoconjunctivitis) can be the first symptom in infected patients. The virus can be present in tear and conjunctival secretions, requiring maximum attention. It\u2019s important to understand if COVID-19 could spread through the ocular route or present as the primary infected site.<\/jats:p>\n<jats:p>Ocular implications should also be considered for therapy. In fact, one potential treatment is chloroquine and its derivatives, including hydroxychloroquine. Hydroxychloroquine, in fact, can induced retinal toxicity.<\/jats:p>\n<jats:p>The exponential increase in lthe number of Covid-19 cases was like a tsunami for health care companies, which were not ready to face this emergency. Ophthalmology departments were also affected by the reorganization of healthcare services.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The studies analaysed have some limitations. First, the sample size and the covered population consisted mainly of patients with mild disease. Moreover, the studies are often descriptive study, without a correlation analysis.<\/jats:p>\n<jats:p>Finally, no normal population was observed in the studies, so a normal control group should be included for comparison in future studies.<\/jats:p>\n<jats:p>With the evolving COVID-19 pandemic and with its high infectivity, it is necessary to rearrange ophthalmologist routine clinical practice in order to control viral spread and try to maximize patient and health-care provider\u2019s safety.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12348-020-00212-4","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:07:03Z","timestamp":1599174423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 and ocular implications: an update"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-832X","authenticated-orcid":false,"given":"Raffaele","family":"Nuzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Ludovico","family":"Carucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Tripoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"212_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jmv.25678","volume":"92","author":"H Lu","year":"2020","unstructured":"Lu H, Stratton C, Tang Y (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92:401\u2013402","journal-title":"J Med Virol"},{"key":"212_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506","journal-title":"Lancet"},{"issue":"3","key":"212_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"X Xu","year":"2020","unstructured":"Xu X, Chen P, Wang J et al (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63(3):457\u2013460","journal-title":"Sci China Life Sci"},{"key":"212_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273","journal-title":"Nature"},{"key":"212_CR5","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1167\/iovs.06-1024","volume":"48","author":"PS Senanayake","year":"2007","unstructured":"Senanayake PS, Drazba J, Shadrach K et al (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48:3301\u20133311","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"212_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bjo.80.2.159","volume":"80","author":"J Wagner","year":"1996","unstructured":"Wagner J, Jan Danser AH, Derkx FH et al (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80:159\u2013163","journal-title":"Br J Ophthalmol"},{"key":"212_CR7","first-page":"783","volume":"6","author":"LL Yan Sun","year":"2006","unstructured":"Yan Sun LL, Pan X, Jing M (2006) Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. J Virol 6:783\u2013786","journal-title":"J Virol"},{"key":"212_CR8","doi-asserted-by":"publisher","unstructured":"Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al (2020) Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: a cross-sectional study. MedRxiv. https:\/\/doi.org\/10.1101\/2020.03.12.20034678.","DOI":"10.1101\/2020.03.12.20034678"},{"key":"212_CR9","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zeng Y, Tong Y, Chen C (2020) Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. medRxiv; https:\/\/doi.org\/10.1101\/2020.02.11.20021956.","DOI":"10.1101\/2020.02.11.20021956"},{"key":"212_CR10","doi-asserted-by":"publisher","unstructured":"Xia J, Tong J, Liu M, Shen Y, Guo D (2020) Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92(6):589\u2013594. https:\/\/doi.org\/10.1002\/jmv.25725.","DOI":"10.1002\/jmv.25725"},{"key":"212_CR11","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.jcjo.2020.03.003","volume":"55","author":"M Cheema","year":"2020","unstructured":"Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 55:e125\u2013e129","journal-title":"Can J Ophthalmol"},{"key":"212_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/bjophthalmol-2020-316304","volume":"104","author":"L Chen","year":"2020","unstructured":"Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang Z, Liu L, Zhang G, Wang J (2020) Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 104:748\u2013751","journal-title":"Br J Ophthalmol"},{"key":"212_CR13","doi-asserted-by":"crossref","unstructured":"Sun X, Zhang X, Chen X, Chen L, Deng C, Zou X, et al (2020) The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study. MedRxIV.","DOI":"10.1101\/2020.02.26.20027938"},{"issue":"10","key":"212_CR14","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/infdis\/jiu292","volume":"210","author":"ZA Memish","year":"2014","unstructured":"Memish ZA, Al-Tawfiq JA, Makhdoom HQ et al (2014) Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 210(10):1590\u20131594","journal-title":"J Infect Dis"},{"issue":"41","key":"212_CR15","doi-asserted-by":"publisher","first-page":"16598","DOI":"10.1073\/pnas.1310744110","volume":"110","author":"E de Wit","year":"2013","unstructured":"de Wit E, Rasmussen AL, Falzarano D et al (2013) Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 110(41):16598\u201316603","journal-title":"Proc Natl Acad Sci U S A"},{"key":"212_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmv.25725","volume":"92","author":"J Xia","year":"2020","unstructured":"Xia J, Tong J, Liu M, Shen Y, Guo D (2020) Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92:589\u2013597","journal-title":"J Med Virol"},{"key":"212_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","volume":"94","author":"D Wu","year":"2020","unstructured":"Wu D, Wu T, Liu Q, Yang Z (2020) The SARS-CoV-2 outbreak: what we know. Int J Infect Dis 94:44\u201348","journal-title":"Int J Infect Dis"},{"key":"212_CR18","volume-title":"Coronavirus disease (COVID-19) advice for the public","author":"World Health Organization","year":"2020","unstructured":"World Health Organization, Coronavirus disease (COVID-19) advice for the public, (2020) Accessed 24 Mar 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel- coronavirus-2019\/advice-for-public"},{"issue":"2","key":"212_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.clae.2018.10.022","volume":"42","author":"D Fonn","year":"2019","unstructured":"Fonn D, Jones L (2019) Hand hygiene is linked to microbial keratitis and corneal in- flammatory events. Cont Lens Anterior Eye 42(2):132\u2013135","journal-title":"Cont Lens Anterior Eye"},{"key":"212_CR20","doi-asserted-by":"publisher","unstructured":"Jones L, Walsh K, Willcox M, Morgan P, Nichols J The COVID-19 pandemic: important considerations for contact lens practitioners. Cont Lens Anterior Eye https:\/\/doi.org\/10.1016\/j.clae.2020.03.012","DOI":"10.1016\/j.clae.2020.03.012"},{"key":"212_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ophtha.2020.03.026","volume":"127","author":"I Jun","year":"2020","unstructured":"Jun I, Anderson DE, Kang AE, Wang L-F, Rao P, Young BE, Lye DC, Agrawal R (2020) Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology 127:977\u2013979","journal-title":"Ophthalmology"},{"issue":"18","key":"212_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, C (2020) China Medical Treatment Expert Group for, Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 382(18):1708\u20131720","journal-title":"N Engl J Med"},{"issue":"3","key":"212_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhin.2020.01.022","volume":"104","author":"G Kampf","year":"2020","unstructured":"Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 104(3):246\u2013251","journal-title":"J Hosp Infect"},{"key":"212_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/jmv.25898","volume":"92","author":"P Sarma","year":"2020","unstructured":"Sarma P et al (2020) Virological and clinical cure in Covid-19 patients treated with Hydroxychloroquine: a systematic review and meta-analysis. J Med Virol 92:776\u2013785","journal-title":"J Med Virol"},{"issue":"3","key":"212_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7861\/clinmed.2020-0129","volume":"20","author":"BR Sturrock","year":"2020","unstructured":"Sturrock BR, Chevassut TJ (2020) Chloroquine and COVID-19 - a potential game changer? Clin Med (Lond) 20(3):278\u2013281","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"212_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3899\/jrheum.190538","volume":"47","author":"KL Carter","year":"2020","unstructured":"Carter KL, Do DV (2020) Hydroxychloroquine-induced retinal toxicity. J Rheumatol 47(4):632","journal-title":"J Rheumatol"},{"issue":"6","key":"212_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"M Marmor","year":"2016","unstructured":"Marmor M, Kellner U, Lai TY, Melles RB, Mieler WF (2016) Recommendations on screening for chloroquine and hydroxy-chloroquine retinopathy (2016 revision). Ophthalmology 123(6):1386\u20131394","journal-title":"Ophthalmology"},{"key":"212_CR28","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"20","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L et al (2020) Hydroxychloroquine and azithromycin as a treatment ofCOVID-19: results of anopen-label non-randomized clinicaltrial. Int J Antimicrob Agents 20:105949","journal-title":"Int J Antimicrob Agents"},{"key":"212_CR29","doi-asserted-by":"publisher","unstructured":"Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW (2020) Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 258(5):1049\u20131055. https:\/\/doi.org\/10.1007\/s00417-020-04641-8.","DOI":"10.1007\/s00417-020-04641-8"},{"key":"212_CR30","first-page":"1997","volume-title":"Telecommunications in health care","author":"MJ Field","year":"1997","unstructured":"Field MJ (1997) Telecommunications in health care, vol 1, p 1997"},{"key":"212_CR31","unstructured":"American Academy of Ophthalmology (2020) Important Coronavirus Updates for Ophthalmologists. Am Acad Ophthalmol. https:\/\/www.aao.org\/headline\/alert-important-coronavirus-context."},{"key":"212_CR32","volume-title":"COVID-19: resources for households","author":"CDC","year":"2020","unstructured":"CDC. COVID-19: resources for households, 2020"},{"key":"212_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/IJG.0000000000001519","volume":"29","author":"M Jeffrey","year":"2020","unstructured":"Jeffrey M, Liebmann MD (2020) Ophthalmology and Glaucoma practice in the COVID-19 era. J Glaucoma 29:407\u2013408","journal-title":"J Glaucoma"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-020-00212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-020-00212-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-020-00212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:31:16Z","timestamp":1630711876000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-020-00212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/s12348-020-00212-4","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests\" in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}